Drug Excipient Compatibility Study of Acyclovir with Other Ingredients in Preformulation stage & Tablet formulation

Authors

  • PRAGYA RANI Himalayan Pharmacy Institute, Majhitar, Sikkim, India -737136
  • Pragya Baghel Himalayan Pharmacy Institute, Majhitar, Sikkim, India -737136
  • Sanjib Bahadur Himalayan Pharmacy Institute, Majhitar, Sikkim, India -737136

DOI:

https://doi.org/10.61114/UJPSR.10.2.2026.1-9

Keywords:

Compatibility studies, Fourier Transform Infrared Spectroscopy, Preformulation, Differential Scanning Calorimetry, High-Performance Liquid Chromatography

Abstract

Studies of active pharmaceutical ingredient (API) - excipient compatibility represent an important study in the Preformulation stage of the development of new dosage forms. The potential physical and chemical interactions between an API and the excipients can affect the chemical nature, the stability and bioavailability of the former and, consequently, its therapeutic efficacy and safety. Drug-excipient compatibility studies are a fundamental aspect of Preformulation research, aimed at ensuring the chemical and physical stability of the active pharmaceutical ingredient (API) within a dosage form. The present study investigates the compatibility of Acyclovir, an antiviral drug primarily used in the treatment of herpes simplex virus infections, with several commonly used pharmaceutical excipients using Fourier Transform Infrared (FTIR) spectroscopy. Upon comparison of FTIR spectra of physical mixtures with those of the individual components, no significant shifts in peak positions, disappearance of characteristic bands, or appearance of new peaks were observed, suggesting the absence of chemical interactions under ambient conditions. Minor variations in peak intensities were noted, possibly due to hydrogen bonding or physical adsorption phenomena, which are not considered detrimental to stability. These results confirm that Acyclovir is compatible with the selected excipients under dry mixing conditions, making them suitable candidates for further formulation development in solid oral dosage forms. The study underscores the utility of FTIR spectroscopy as a rapid, cost-effective, and reliable method for preliminary screening of drug-excipient compatibility and for reducing the risk of instability in the later stages of pharmaceutical product development.

References

1. Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. International Journal of Pharmaceutical Excipients. 2016 Nov 23;1(3).

2. Moyano M, Broussalis A, Segall A. Thermal analysis of lipoic acid and evaluation of the compatibility with excipients. Journal of thermal analysis and calorimetry. 2010 Feb 1;99(2):631-7.

3. Ceresole R, Han Y, Rosasco MA, Orelli LR, Segall AI: Drug-excipient compatibility studies in binary mixtures of Avobenzone. J. Cosmet. Sci. 2013; 64: 317-328.

4. Chadha R, Bhandari S. Drug–excipient compatibility screening—role of thermoanalytical and spectroscopic techniques. Journal of pharmaceutical and biomedical analysis. 2014 Jan:82-97.

5. McDaid FM, Barker SA, Fitzpatrick S, Petts CR, Craig DQ. Further investigations into the use of high sensitivity differential scanning calorimetry as a means of predicting drug–excipient interactions. International journal of pharmaceutics. 2003 Feb 18;252(1-2):235-40.

6. O’Neill MA, Gaisford S. Application and use of isothermal calorimetry in pharmaceutical development. International journal of pharmaceutics. 2011 Sep 30;417(1-2):83-93.

7. Pinto M, de Moura E, de Souza F, Macêdo R. Thermal compatibility studies of nitroimidazoles and excipients. Journal of thermal analysis and calorimetry. 2010 Oct 1;102(1):323-9.

8. Santos AF, Basilio ID, De Souza FS, Medeiros AF, Pinto MF, De Santana DP, Macêdo RO. Application of thermal analysis in study of binary mixtures with metformin. Journal of thermal analysis and calorimetry. 2008 Aug; 93:361-4.

9. Chou Y, Huang J, Tseng J, Cheng S, Shu C. Reaction hazard analysis for the thermal decomposition of cumene hydroperoxide in the presence of sodium hydroxide. Journal of thermal analysis and calorimetry. 2008 Jul 1;93(1):275-80.

10. Sashina E, Janowska G, Zaborski M, Vnuchkin A. Compatibility of fibroin/chitosan and fibroin/cellulose blends studied by thermal analysis. Journal of thermal analysis and calorimetry. 2007 Sep 1;89(3):887-91.

11. Medeiros A, Santos A, de Souza F, Junior I, Valdilânio J, Procopio J, de Santana D, Macedo R. Thermal studies of pre-formulates of metronidazole obtained by spray drying technique. Journal of thermal analysis and calorimetry. 2007 Sep 1;89(3):775-81.

12. Silva MA, Kelmann RG, Foppa T, Cruz AP, Bertol CD, Sartori T, Granada A, Carmignan F, Murakami FS. Thermoanalytical study of fluoxetine hydrochloride. Journal of thermal analysis and calorimetry. 2007 Jan 1;87(2):463-7.

13. Lira AM, Araújo AA, Basílio ID, Santos BL, Santana DP, Macedo RO. Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations. Thermochimica acta. 2007 Jun 15;457(1-2):1-6.

14. Mura P, Furlanetto S, Cirri M, Maestrelli F, Marras AM, Pinzauti S. Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design. Journal of Pharmaceutical and biomedical Analysis. 2005 Feb 7;37(1):65-71.

15. Araújo AA, Storpirtis S, Mercuri LP, Carvalho FM, dos Santos Filho M, Matos JR. Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. International journal of pharmaceutics. 2003 Jul 24;260(2):303-14.

16. Matos AP, Costa JS, Boniatti J, Seiceira RC, Pitaluga A, Oliveira DL, Viçosa AL, Holandino C. Compatibility study between diazepam and tablet excipients: Infrared spectroscopy and thermal analysis in accelerated stability conditions. Journal of Thermal Analysis and Calorimetry. 2017 Feb; 127:1675-82.

17. Liltorp K, Larsen TG, Willumsen B, Holm R. Solid state compatibility studies with tablet excipients using non thermal methods. Journal of pharmaceutical and biomedical analysis. 2011 Jun 1;55(3):424-8.

18. Verma RK, Garg S. Selection of excipients for extended -release formulations of glipizide through drug–excipient compatibility testing. Journal of pharmaceutical and biomedical analysis. 2005 Jul 15;38(4):633-44.

19. Verma RK, Garg S. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended-release formulations. Journal of pharmaceutical and biomedical analysis. 2004 May 28;35(3):449-58.

20. Silva LA, Teixeira FV, Serpa RC, Esteves NL, dos Santos RR, Lima EM, da Cunha-Filho MS, de Souza Araújo AA, Taveira SF, Marreto RN. Evaluation of carvedilol compatibility with lipid excipients for the development of lipid-based drug delivery systems. Journal of thermal analysis and calorimetry. 2016 Mar; 123:2337-44.

21. Veiga A, Oliveira PR, Bernardi LS, Mendes C, Silva MA, Sangoi MS, Janissek PR, Murakami FS. Solid-state compatibility studies of a drug without melting point: The case of omeprazole sodium. Journal of Thermal Analysis and Calorimetry. 2018 Mar; 131:3201-9.

22. Rus LM, Tomuta IO, Iuga C, Maier CO, Kacso I, Borodi GH, Bratu I, Bojita MA. Compatibility studies of indapamide/pharmaceutical excipients used in tablet preformulation. Farmacia. 2012 Jan 1;60(1):92-101.

23. Tomassetti M, Catalani A, Rossi V, Vecchio S. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures. Journal of pharmaceutical and biomedical analysis. 2005 Apr 29;37(5):949-55.

24. Ding T, Chen L, Zhai LH, Fu Y, Sun BW. Compatibility study of rivaroxaban and its pharmaceutical excipients. Journal of thermal analysis and calorimetry. 2017 Dec; 130:1569-73.

25. Pires SA, Mussel WN, Yoshida MI. Solid-state characterization and pharmaceutical compatibility between citalopram and excipients using thermal and non-thermal techniques. Journal of Thermal Analysis and Calorimetry. 2017 Jan; 127:535-42.

26. Joshi BV, Patil VB, Pokharkar VB. Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods. Drug development and industrial pharmacy. 2002 Jan 1;28(6):687-94.

27. Chadha R, Bhandari S. Drug–excipient compatibility screening—role of thermoanalytical and spectroscopic techniques. Journal of pharmaceutical and biomedical analysis. 2014 Jan 18; 87:82-97.

28. Jinnawar KS, Gupta KR. Drug excipient compatibility study using thermal and non-thermal methods of analysis. Int J Chem tech Applications. 2012;2(2):23-49.

29. Serajuddin AT, Thakur AB, Ghoshal RN, Fakes MG, Ranadive SA, Morris KR, Varia SA. Selection of solid dosage form composition through drug–excipient compatibility testing. Journal of pharmaceutical sciences. 1999 Jul;88(7):696-704.

30. Marini A, Berbenni V, Moioli S, Bruni G, Cofrancesco P, Margheritis C, Villa M. Drug-excipient compatibility studies by physico-chemical techniques; The case of Indomethacin. Journal of thermal analysis and calorimetry. 2003 Aug 1;73(2):529-45.

Downloads

Published

19-11-2026

Issue

Section

Articles

How to Cite

Drug Excipient Compatibility Study of Acyclovir with Other Ingredients in Preformulation stage & Tablet formulation. (2026). UNIVERSAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 10(2), 1-9. https://doi.org/10.61114/UJPSR.10.2.2026.1-9